Cargando…
Ex Vivo Effect of Varespladib on Secretory Phospholipase A2 Alveolar Activity in Infants with ARDS
BACKGROUND: Secretory phospholipase A2 (sPLA2) plays a pivotal role in acute respiratory distress syndrome (ARDS). This enzyme seems an interesting target to reduce surfactant catabolism and lung tissue inflammation. Varespladib is a specifically designed indolic sPLA2 inhibitor, which has shown pro...
Autores principales: | De Luca, Daniele, Minucci, Angelo, Piastra, Marco, Cogo, Paola E., Vendittelli, Francesca, Marzano, Laura, Gentile, Leonarda, Giardina, Bruno, Conti, Giorgio, Capoluongo, Ettore D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469496/ https://www.ncbi.nlm.nih.gov/pubmed/23071714 http://dx.doi.org/10.1371/journal.pone.0047066 |
Ejemplares similares
-
Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants
por: De Luca, Daniele, et al.
Publicado: (2013) -
The BRAVO Clinical Study Protocol: Oral Varespladib for Inhibition of Secretory Phospholipase A2 in the Treatment of Snakebite Envenoming
por: Carter, Rebecca W., et al.
Publicado: (2022) -
Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study
por: De Luca, Daniele, et al.
Publicado: (2011) -
A-002 (Varespladib), a phospholipase A(2 )inhibitor, reduces atherosclerosis in guinea pigs
por: Leite, Jose O, et al.
Publicado: (2009) -
Varespladib Inhibits the Phospholipase A(2) and Coagulopathic Activities of Venom Components from Hemotoxic Snakes
por: Xie, Chunfang, et al.
Publicado: (2020)